Sio Gene Therapies Inc
(SIOX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,594 | -72,628 | -55,980 | -41,941 | -28,057 |
| Depreciation Amortization | 492 | 1,477 | 1,175 | 734 | 426 |
| Accounts payable and accrued liabilities | -1,442 | 2,710 | -1,351 | -131 | 1,198 |
| Other Working Capital | -5,281 | -4,887 | -603 | 1,304 | 8,343 |
| Other Operating Activity | 1,322 | 5,855 | 7,196 | 3,557 | 359 |
| Operating Cash Flow | $-13,503 | $-67,473 | $-49,563 | $-36,477 | $-17,731 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19 | -255 | -250 | -174 | -78 |
| Investing Cash Flow | $-19 | $-255 | $-250 | $-174 | $-78 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -15,731 | -29,563 | -29,563 | -10,255 | -5,047 |
| Common Stock Issued | 3,930 | 70,896 | 86 | 86 | 5 |
| Other Financing Activity | 53 | 148 | 103 | 76 | 28 |
| Financing Cash Flow | $-11,748 | $41,481 | $-29,374 | $-10,093 | $-5,014 |
| Beginning Cash Position | 80,752 | 106,999 | 106,999 | 106,999 | 106,999 |
| End Cash Position | 55,482 | 80,752 | 27,812 | 60,255 | 84,176 |
| Net Cash Flow | $-25,270 | $-26,247 | $-79,187 | $-46,744 | $-22,823 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,503 | -67,473 | -49,563 | -36,477 | -17,731 |
| Capital Expenditure | -19 | -255 | -250 | -174 | -78 |
| Free Cash Flow | -13,522 | -67,728 | -49,813 | -36,651 | -17,809 |